NASDAQ-GS · traded in Congress
Vaxcyte, PCVX
$64.29 +0.40 (+0.63%) Nov 9, 2026 4:30 AM ET
Market value$10.2B
P/E ratio-
Analyst target$121.00
52-week range-
Avg volume2,385,959
Dividend yieldN/A
Chart
Analyst ratings
- 9 buy
- 1 hold
- 0 sell
Low target$75.00
Average target$116.40
High target$163.00
Congress trades in PCVX
Members of Congress disclosed 3 transactions in PCVX in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 07/16/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 9/4/2026 filing |
| 05/13/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
| 05/12/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
